FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giacomo Zoppini

Research Profile

Disorders

Geographic Areas

Italy

Chemicals & Drugs

Concepts & Ideas

Physiology

Glomerular Filtration Rate

Co-author Network

Publications

TOP 3
Giacomo Zoppini; Michel Chonchol; Carlo Negri; Vittorio Ortalda; Vincenzo Stoico; Giovanni Targher; Enzo Bonora
Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
A Mantovani; Giovanni Targher; Giacomo Zoppini; G Golia; Enzo Bonora
Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals.
Giovanni Targher; Giacomo Zoppini; Christopher P Day
Risk of all-cause and cardiovascular mortality in patients with chronic liver disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giacomo Zoppini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Giacomo Zoppini; Michel Chonchol; Carlo Negri; Vittorio Ortalda; Vincenzo Stoico; Giovanni Targher; Enzo Bonora
Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(3):401-8.
2012: A Mantovani; Giovanni Targher; Giacomo Zoppini; G Golia; Enzo Bonora
Non-alcoholic fatty liver disease is independently associated with left ventricular hypertrophy in hypertensive Type 2 diabetic individuals.
Journal of endocrinological investigation 2012;35(2):215-8.
2011: Giovanni Targher; Giacomo Zoppini; Christopher P Day
Risk of all-cause and cardiovascular mortality in patients with chronic liver disease.
Gut 2011;60(11):1602-3; author reply 1603-4.
2011: Massimiliano Lanzafame; Emanuela Lattuada; Giacomo Zoppini; Sandro Vento
Antiretroviral therapy-associated diseases are common in the long-term.
AIDS research and human retroviruses 2011;27(9):931-2.
2011: Enzo Bonora; Stefan Kiechl; James B Meigs; Friedrich Oberhollenzer; Giovanni Targher; Johann Willeit; Giacomo Zoppini; Riccardo C Bonadonna; Michele Muggeo
Impact of reference category and number of traits in the cluster on risk of coronary heart disease in metabolic syndrome: prospective data from the Bruneck study.
Metabolic syndrome and related disorders 2011;9(4):313-8.
2011: Giovanni Targher; Michel Chonchol; I Pichiri; Giacomo Zoppini
Risk of cardiovascular disease and chronic kidney disease in diabetic patients with non-alcoholic fatty liver disease: just a coincidence?
Journal of endocrinological investigation 2011;34(7):544-51.
2011: Giovanni Targher; Michel Chonchol; Giacomo Zoppini; Cataldo Abaterusso; Enzo Bonora
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link?
Journal of hepatology 2011;54(5):1020-9.
2011: Giovanni Targher; Giacomo Zoppini; Michel Chonchol; C Negri; V Stoico; F Perrone; Michele Muggeo; Enzo Bonora
Glomerular filtration rate, albuminuria and risk of cardiovascular and all-cause mortality in type 2 diabetic individuals.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2011;21(4):294-301.
2011: Giovanni Targher; Michel Chonchol; Giacomo Zoppini; Massimo Franchini
Hemostatic disorders in type 1 diabetes mellitus.
Seminars in thrombosis and hemostasis 2011;37(1):58-65.
2010: Giovanni Targher; Lorenzo Bertolini; Stefania Rodella; Giuseppe Lippi; Giacomo Zoppini; Michel Chonchol
Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(12):2166-71.
2010: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Stefania Rodella; Giacomo Zoppini; Isabella Pichiri; Claudia Sorgato; Luciano Zenari; Enzo Bonora
Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease in patients with type 1 diabetes.
Journal of hepatology 2010;53(4):713-8.
2010: Giacomo Zoppini; Giovanni Targher; Carlo Negri; Vincenzo Stoico; Maria Luisa Gemma; Enzo Bonora
Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Atherosclerosis 2010;212(1):287-91.
2010: Giovanni Targher; L Bertolini; Michel Chonchol; Stefania Rodella; Giacomo Zoppini; Giuseppe Lippi; Luciano Zenari; Enzo Bonora
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients.
Diabetologia 2010;53(7):1341-8.
2010: Giacomo Zoppini; Giovanni Targher; Michel Chonchol; Carlo Negri; Vincenzo Stoico; Isabella Pichiri; Giuseppe Lippi; Michele Muggeo; Enzo Bonora
Anaemia, independent of chronic kidney disease, predicts all-cause and cardiovascular mortality in type 2 diabetic patients.
Atherosclerosis 2010;210(2):575-80.
2010: Giovanni Targher; Giacomo Zoppini; Paolo Moghetti; Chris P Day
Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver.
Seminars in thrombosis and hemostasis 2010;36(1):41-8.
2010: Stefano Casati; Giacomo Zoppini; Michele Muggeo; Giorgio Marchini
Sustained regression of florid diabetic retinopathy in a patient with Donohue syndrome (leprechaunism).
European journal of ophthalmology 2010;20(1):224-7.
2009: Flavia Tosi; Romolo Dorizzi; Roberto Castello; Claudio Maffeis; Giovanna Spiazzi; Giacomo Zoppini; Michele Muggeo; Paolo Moghetti
Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 2009;161(5):737-45.
2009: Giovanni Targher; Isabella Pichiri; Giacomo Zoppini; Enzo Bonora; Michel Chonchol
Hemostatic and fibrinolytic abnormalities in endocrine diseases: a narrative review.
Seminars in thrombosis and hemostasis 2009;35(7):605-12.
2009: Paolo Gisondi; Giovanni Targher; Giacomo Zoppini; Giampiero Girolomoni
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis.
Journal of hepatology 2009;51(4):758-64.
2009: Giacomo Zoppini; Giovanni Targher; Michel Chonchol; F Perrone; Giuseppe Lippi; Michele Muggeo
Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(8):580-6.
2009: Giovanni Targher; E Solagna; Flavia Tosi; Roberto Castello; Giovanna Spiazzi; Giacomo Zoppini; Michele Muggeo; Christopher P Day; Paolo Moghetti
Abnormal serum alanine aminotransferase levels are associated with impaired insulin sensitivity in young women with polycystic ovary syndrome.
Journal of endocrinological investigation 2009;32(8):695-700.
2009: Giacomo Zoppini; Giovanni Targher; Carlo Negri; Vincenzo Stoico; Fabrizia Perrone; Michele Muggeo; Enzo Bonora
Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients.
Diabetes care 2009;32(9):1716-20.
2009: Giacomo Zoppini; G Verlato; Giovanni Targher; S Casati; E Gusson; V Biasi; F Perrone; Enzo Bonora; Michele Muggeo
Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(5):334-9.
2009: Giovanni Targher; Michel Chonchol; Luca Miele; Giacomo Zoppini; Isabella Pichiri; Michele Muggeo
Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
Seminars in thrombosis and hemostasis 2009;35(3):277-87.
2009: Giovanni Targher; Giacomo Zoppini; Gian Cesare Guidi; Giuseppe Lippi
Relationship between serum bilirubin and kidney function in non-diabetic and diabetic individuals.
Kidney international 2009;75(8):863.
2009: Giovanni Targher; Michel Chonchol; Giacomo Zoppini; Gianluca Salvagno; Isabella Pichiri; Massimo Franchini; Giuseppe Lippi
Prevalence of thyroid autoimmunity and subclinical hypothyroidism in persons with chronic kidney disease not requiring chronic dialysis.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2009;47(11):1367-71.
2008: Giacomo Zoppini; Giovanni Targher; M Trombetta; Giuseppe Lippi; Michele Muggeo
Relationship between soluble CD40 ligand and gamma-glutamyltransferase concentrations in non-drinking, young Type 1 diabetic individuals.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(11):1283-8.
2008: Giacomo Zoppini; Giuseppe Verlato; Giovanni Targher; Enzo Bonora; Maddalena Trombetta; Michele Muggeo
Variability of body weight, pulse pressure and glycaemia strongly predict total mortality in elderly type 2 diabetic patients. The Verona Diabetes Study.
Diabetes/metabolism research and reviews 2008;24(8):624-8.
2008: Michel Chonchol; Giuseppe Lippi; Gianluca Salvagno; Giacomo Zoppini; Michele Muggeo; Giovanni Targher
Prevalence of subclinical hypothyroidism in patients with chronic kidney disease.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(5):1296-300.
2008: Giovanni Targher; Michel Chonchol; Lorenzo Bertolini; Stefano Rodella; Luciano Zenari; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo
Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease.
Journal of the American Society of Nephrology : JASN 2008;19(8):1564-70.
2008: Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giuseppe Lippi; Massimo Franchini; Giacomo Zoppini; Michele Muggeo; Christopher P Day
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men.
Obesity (Silver Spring, Md.) 2008;16(6):1394-9.
2008: Giovanni Targher; Giacomo Zoppini; Michele Muggeo
Differential relationships between basal and post-load insulin resistance indices and hepatic fibrosis in chronic hepatitis C and in non-alcoholic fatty liver disease.
Gut 2008;57(3):426; author reply 426-7.
2008: Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giacomo Zoppini; Giuseppe Lippi; Christopher P Day; Michele Muggeo
Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients.
Diabetologia 2008;51(3):444-50.
2008: Livio Luzi; Giacomo Zoppini; Giovanni Targher; Alberto Battezzati; Michele Muggeo; Enzo Bonora
Insulin effect on serum potassium and auto-inhibition of insulin secretion is intact in a patient with leprechaunism despite severe impairment of substrates metabolism.
Diabetes/metabolism research and reviews 2008;24(3):205-10.
2008: Giovanni Targher; Martina Montagnana; Gianluca Salvagno; Paolo Moghetti; Giacomo Zoppini; Michele Muggeo; Giuseppe Lippi
Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients.
Clinical endocrinology 2008;68(3):481-4.
2008: Giuseppe Lippi; Giovanni Targher; Martina Montagnana; Gian Luca Salvagno; Giacomo Zoppini; Gian Cesare Guidi
Relationship between red blood cell distribution width and kidney function tests in a large cohort of unselected outpatients.
Scandinavian journal of clinical and laboratory investigation 2008;68(8):745-8.
2008: Giovanni Targher; Lorenzo Bertolini; Luciano Zenari; Giuseppe Lippi; I Pichiri; Giacomo Zoppini; Michele Muggeo; Guido Arcaro
Diabetic retinopathy is associated with an increased incidence of cardiovascular events in Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2008;25(1):45-50.
2007: Giovanni Targher; Giacomo Zoppini; Giuseppe Lippi; Gian Cesare Guidi; Michele Muggeo
Effect of serum gamma-glutamyltransferase and obesity on the risk of dyslipidemia and poor glycemic control in type 2 diabetic patients: cross-sectional findings from the Verona Diabetes Study.
Clinical chemistry 2007;53(10):1867-9; author reply 1869-70.
2007: Giovanni Targher; Lorenzo Bertolini; Giacomo Zoppini; Giuseppe Lippi; Luciano Zenari
Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
Diabetes care 2007;30(6):e51; author reply e52.
2007: Giacomo Zoppini; Vittorio Cacciatori; ML Gemma; Paolo Moghetti; Giovanni Targher; Cristina Zamboni; K Thomaseth; F Bellavere; Michele Muggeo
Effect of moderate aerobic exercise on sympatho-vagal balance in Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(4):370-6.
2007: Giacomo Zoppini; Giuseppe Verlato; Cristina Zamboni; Cristina Venturi; Nicola Gennaro; Valeria Biasi; Enzo Bonora; Michele Muggeo
Pulse pressure and mortality from cerebrovascular diseases in type 2 diabetic patients: the Verona Diabetes Study.
Cerebrovascular diseases (Basel, Switzerland) 2007;23(1):20-6.
2006: Giacomo Zoppini; Giovanni Targher; Cristina Zamboni; Cristina Venturi; Vittorio Cacciatori; Paolo Moghetti; Michele Muggeo
Effects of moderate-intensity exercise training on plasma biomarkers of inflammation and endothelial dysfunction in older patients with type 2 diabetes.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2006;16(8):543-9.
2006: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Stefano Rodella; Giacomo Zoppini; Luciano Zenari; Massimo Cigolini; Giancarlo Falezza; Guido Arcaro
Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease.
Diabetes care 2006;29(6):1325-30.
2006: Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giacomo Zoppini; Luca Scala; Luciano Zenari; Giancarlo Falezza
Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease.
Clinical endocrinology 2006;64(6):679-83.
2006: Giovanni Targher; Lorenzo Bertolini; Stefano Rodella; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
Clinical endocrinology 2006;64(3):337-41.
2006: M Elisabetta Zanolin; Flavia Tosi; Giacomo Zoppini; Roberto Castello; Giovanna Spiazzi; Romolo Dorizzi; Michele Muggeo; Paolo Moghetti
Clustering of cardiovascular risk factors associated with the insulin resistance syndrome: assessment by principal component analysis in young hyperandrogenic women.
Diabetes care 2006;29(2):372-8.
2006: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Felice Poli; Luca Scala; Luciano Zenari; Giacomo Zoppini; Giancarlo Falezza
Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
Journal of endocrinological investigation 2006;29(1):55-60.
2005: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2687-8.
2005: M Trombetta; Giovanna Spiazzi; Giacomo Zoppini; Michele Muggeo
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.
Alimentary pharmacology & therapeutics 2005;22 Suppl 2():24-7.
2005: Giovanni Targher; Lorenzo Bertolini; Luca Scala; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(10):1354-8.
2005: Giovanni Targher; Lorenzo Bertolini; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Relationship of non-alcoholic hepatic steatosis to cortisol secretion in diet-controlled Type 2 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(9):1146-50.
2005: Giovanni Targher; Lorenzo Bertolini; Giacomo Zoppini; Luciano Zenari; Giancarlo Falezza
Increased plasma markers of inflammation and endothelial dysfunction and their association with microvascular complications in Type 1 diabetic patients without clinically manifest macroangiopathy.
Diabetic medicine : a journal of the British Diabetic Association 2005;22(8):999-1004.
2004: Giacomo Zoppini; Giovanni Targher; Cristina Venturi; Cristina Zamboni; Michele Muggeo
Relationship of nonalcoholic hepatic steatosis to overnight low-dose dexamethasone suppression test in obese individuals.
Clinical endocrinology 2004;61(6):711-5.
2004: Giovanni Targher; Lorenzo Bertolini; Roberto Padovani; Luciano Zenari; Giacomo Zoppini; Giancarlo Falezza
Relation of nonalcoholic hepatic steatosis to early carotid atherosclerosis in healthy men: role of visceral fat accumulation.
Diabetes care 2004;27(10):2498-500.
2004: Antonio Nicolucci; R Giorgino; D Cucinotta; Giacomo Zoppini; Michele Muggeo; S Squatrito; A Corsi; S Lostia; L Pappalardo; E Benaduce; A Girelli; F Galeone; A Maldonato; Gabriele Perriello; P Pata; G Marra; GA Coronel
Validation of the Italian version of the WHO-Well-Being Questionnaire (WHO-WBQ) and the WHO-Diabetes Treatment Satisfaction Questionnaire (WHO-DTSQ).
Diabetes, nutrition & metabolism 2004;17(4):235-43.
2004: Cristina Venturi; Giacomo Zoppini; Cristina Zamboni; Michele Muggeo
Insulin sensitivity and hepatic steatosis in obese subjects with normal glucose tolerance.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2004;14(4):200-4.
2004: Giovanni Targher; Giacomo Zoppini
Soluble CD40L in young type 1 diabetic individuals without clinical microvascular and macrovascular complications.
Diabetes care 2004;27(5):1236-7.
2003: Giacomo Zoppini
The role of general practitioners in epidemiological research.
Diabetes, nutrition & metabolism 2003;16(3):191-3.
2003: Giuseppe Verlato; Giacomo Zoppini; Enzo Bonora; Michele Muggeo
Mortality from site-specific malignancies in type 2 diabetic patients from Verona.
Diabetes care 2003;26(4):1047-51.
2003: Giacomo Zoppini; M Carlini; Michele Muggeo
Self-reported exercise and quality of life in young type 1 diabetic subjects.
Diabetes, nutrition & metabolism 2003;16(1):77-80.
2003: Giacomo Zoppini; Giuseppe Verlato; C Leuzinger; Cristina Zamboni; Elisabetta Brun; Enzo Bonora; Michele Muggeo
Body mass index and the risk of mortality in type II diabetic patients from Verona.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2003;27(2):281-5.
2001: Elisabetta Brun; Giacomo Zoppini; Cristina Zamboni; Enzo Bonora; Michele Muggeo
Glucose instability is associated with a high level of circulating p-selectin.
Diabetes care 2001;24(9):1685.
2001: Giacomo Zoppini; Giovanni Faccini; Michele Muggeo; Luciano Zenari; Giancarlo Falezza; Giovanni Targher
Elevated plasma levels of soluble receptors of TNF-alpha and their association with smoking and microvascular complications in young adults with type 1 diabetes.
The Journal of clinical endocrinology and metabolism 2001;86(8):3805-8.
2001: Giovanni Targher; Luciano Zenari; Lorenzo Bertolini; Giancarlo Falezza; Michele Muggeo; Giacomo Zoppini
Plasma total homocysteine levels are associated with von Willebrand factor, soluble intercellular adhesion molecule-1, and soluble tumor necrosis factor-alpha receptors in young type 1 diabetic patients without clinical evidence of macrovascular complications.
Diabetes care 2001;24(8):1496-7.
2001: Giovanni Targher; Luciano Zenari; Lorenzo Bertolini; Michele Muggeo; Giacomo Zoppini
Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications.
Diabetes care 2001;24(5):956-7.
2001: Giovanni Targher; Luciano Zenari; Giovanni Faccini; Giancarlo Falezza; Michele Muggeo; Giacomo Zoppini
Serum leptin concentrations in young smokers with type 1 diabetes.
Diabetes care 2001;24(4):793.
2000: Vittorio Cacciatori; ML Gemma; F Bellavere; Roberto Castello; M E De Gregori; Giacomo Zoppini; K Thomaseth; Paolo Moghetti; Michele Muggeo
Power spectral analysis of heart rate in hypothyroidism.
European journal of endocrinology / European Federation of Endocrine Societies 2000;143(3):327-33.
2000: Elisabetta Brun; Robert G Nelson; P H Bennett; Giuseppina Imperatore; Giacomo Zoppini; Giuseppe Verlato; Michele Muggeo
Diabetes duration and cause-specific mortality in the Verona Diabetes Study.
Diabetes care 2000;23(8):1119-23.
2000: Giovanni Targher; Lorenzo Bertolini; Luciano Zenari; Vittorio Cacciatori; Michele Muggeo; Giovanni Faccini; Giacomo Zoppini
Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes.
Diabetes care 2000;23(4):524-8.
2000: Michele Muggeo; Giacomo Zoppini; Enzo Bonora; Elisabetta Brun; Riccardo C Bonadonna; Paolo Moghetti; Giuseppe Verlato
Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
Diabetes care 2000;23(1):45-50.
1999: Giacomo Zoppini; Giovanni Targher; Vittorio Cacciatori; A Guerriero; Michele Muggeo
Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients.
Diabetes care 1999;22(11):1871-4.
1999: Giacomo Zoppini; Giuseppe Verlato; Enzo Bonora; Michele Muggeo
Attending the diabetes center is associated with reduced cardiovascular mortality in type 2 diabetic patients: the Verona Diabetes Study.
Diabetes/metabolism research and reviews 1999;15(3):170-4.
1999: R de Marco; F Locatelli; Giacomo Zoppini; Giuseppe Verlato; Enzo Bonora; Michele Muggeo
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
Diabetes care 1999;22(5):756-61.
1998: Giacomo Zoppini; P Galante; M Zardini; Michele Muggeo
Insulin induces tyrosine dephosphorylation of a 92 kDA protein in suspended monocytes.
Journal of endocrinological investigation 1998;21(2):93-7.
1997: Michele Muggeo; Giuseppe Verlato; Enzo Bonora; Giacomo Zoppini; M Corbellini; R de Marco
Long-term instability of fasting plasma glucose, a novel predictor of cardiovascular mortality in elderly patients with non-insulin-dependent diabetes mellitus: the Verona Diabetes Study.
Circulation 1997;96(6):1750-4.
1996: Giacomo Zoppini; Giovanni Targher; T Monauni; Giovanni Faccini; E Pasqualini; C Martinelli; M L Zenari; Michele Muggeo
Increase in circulating products of lipid peroxidation in smokers with IDDM.
Diabetes care 1996;19(11):1233-6.
1994: Giacomo Zoppini; P Galante; M Zardini; Michele Muggeo
Phosphotyrosine protein profiles in monocytes after insulin and IGF-1 stimulation.
European journal of clinical investigation 1994;24(4):275-8.
1993: Michele Muggeo; Paolo Moghetti; M Querena; Vittorio Cacciatori; Giacomo Zoppini; MB Zenere; Flavia Tosi; D Travia; Enzo Bonora
Mononuclear leukocytes from obese patients with type II diabetes have reduced activity of hexokinase, 6-phosphofructokinase and glucose-6-phosphate dehydrogenase.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1993;25(3):160-4.
1992: Enzo Bonora; Paolo Moghetti; M Querena; MB Zenere; Vittorio Cacciatori; Flavia Tosi; D Travia; Giacomo Zoppini; Michele Muggeo
Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.
Journal of endocrinological investigation 1992;15(1):1-11.
1990: Enzo Bonora; Paolo Moghetti; Vittorio Cacciatori; MB Zenere; Flavia Tosi; D Travia; Giacomo Zoppini; L Perobelli; Michele Muggeo
Plasma concentrations of glucagon during hyperglycemic clamp with or without somatostatin infusion in obese subjects.
Acta diabetologica latina 1990;27(4):309-14.
1988: Enzo Bonora; Paolo Moghetti; M Querena; M Cigolini; Vittorio Cacciatori; P Carassai; Giacomo Zoppini; Michele Muggeo
[Intracellular enzymes of glucose metabolism in obesity and diabetes].
Minerva endocrinologica 1988;13(4):275-8.